SmART-TBI: Supplementation With Amino Acid Rehabilitative Therapy in TBI
Key facts
- Who runs it
- VA Office of Research and Development
- Where
- Portland, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 175 people enrolled
- Started
- 1 Jun 2021
- Ended
- 30 Sept 2025
- Type of study
- Interventional, 4 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Branched Chain Amino Acids
- Protein Control
- Record updated
- 28 October 2026
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (17)Hide the full registry criteria
Who can take part
- Be Veterans (male and female; any race; 18-65 years of age)
- Be English speaking
- Be accessible via phone
- Be non-decisionally impaired
- Attest to there being no chance of being or becoming pregnant during the study (if female)
- Attest to no history of maple syrup urine disease or known family history of maple urine syrup disease
- Have either a history of self-reported sleep disturbances, either as determined via the Insomnia Severity Index, Functional Outcomes of Sleep Questionnaire or Epworth Sleepiness Scale, clinical assessment, and/or a history of self-reported cognitive disturbance (e.g., poor memory, concentration, attention)
- Not have an allergy to sucralose
- Not be a shift worker (e.g. have worked night or rotating shifts more than twice in the past month)
- Not have a diagnosis of amyotrophic lateral sclerosis
- Not be currently supplementing their diet with branched chain amino acids
- Not be starting another sleep intervention (e.g., positive airway pressure therapy for sleep apnea, sedative-hypnotic medication, or cognitive behavioral therapy for insomnia) during the study; if already engaged in another sleep intervention, this must be stable and not undergo further changes during the study
- Meet diagnostic criteria for TBI using a validated clinical interview
Who cannot take part
- Known history of maple syrup urine disease
- Dementia
- Under 18 years old
- Pregnancy or female trying to conceive
Where in United States
- VA Portland Health Care System, Portland, ORPortland, United States
About the trial
What the trial wants to find out
The most persistent and disabling postconcussive symptoms following mild traumatic brain injury (mTBI) are sleep disturbances and cognitive dysfunction, with few tractable interventions currently available. Here, a novel therapy will be tested consisting of dietary supplementation with branched chain amino acids (BCAA), based on the study team's previous preclinical work showing restoration of glutamate neurotransmitter balance in sleep and memory circuits. Supplementation with Amino acid Rehabilitative Therapy in TBI (SmART-TBI) is a randomized, placebo-controlled, double-blinded, exploratory clinical trial of BCAA intended to establish the feasibility, acceptability, and limited efficacy of long-term BCAA to improve sleep and cognition in Veterans with mTBI. These results will inform the optimal study design of a future, full-scale randomized controlled trial, including the identification of the proper dose and duration of BCAA to improve sleep and the potential subpopulations of Veterans with mTBI that may benefit the most.
The 4 groups in the trial
- BCAA 20g/dailyTreatment being tested
Branched Chain Amino Acids, 10g BID x 12 weeks
Treatment: Branched Chain Amino Acids
- BCAA 40g/dailyTreatment being tested
Branched Chain Amino Acids, 20g BID x 12 weeks
Treatment: Branched Chain Amino Acids
- BCAA 60g/dailyTreatment being tested
Branched Chain Amino Acids, 30g BID x 12 weeks
Treatment: Branched Chain Amino Acids
- Placebo 20g/dailyPlacebo, for comparison
Protein without BCAA, 10g BID x 12 weeks
Treatment: Protein Control
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Supplementation With Amino Acid Rehabilitative Therapy in TBI (SmART-TBI): A Randomized Placebo-Controlled Trial to Improve Sleep
- Record updated
- 28 October 2026